444 related articles for article (PubMed ID: 23977667)
1. Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance.
Smith-Marsh D
Drugs Today (Barc); 2013 Aug; 49(8):499-507. PubMed ID: 23977667
[TBL] [Abstract][Full Text] [Related]
2. Reflecting on type 2 diabetes prevention: more questions than answers!
Rosenstock J
Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
[TBL] [Abstract][Full Text] [Related]
3. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
Flórez H
Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
[TBL] [Abstract][Full Text] [Related]
4. Preservation of β-cell function: the key to diabetes prevention.
DeFronzo RA; Abdul-Ghani MA
J Clin Endocrinol Metab; 2011 Aug; 96(8):2354-66. PubMed ID: 21697254
[TBL] [Abstract][Full Text] [Related]
5. Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
Petersen JL; McGuire DK
Diab Vasc Dis Res; 2005 Feb; 2(1):9-15. PubMed ID: 16305067
[TBL] [Abstract][Full Text] [Related]
6. Identification and treatment of prediabetes to prevent progression to type 2 diabetes.
Fonseca VA
Clin Cornerstone; 2007; 8(2):10-8; discussion 19-20. PubMed ID: 18357952
[TBL] [Abstract][Full Text] [Related]
7. What are the pharmacotherapy options for treating prediabetes?
Daniele G; Abdul-Ghani M; DeFronzo RA
Expert Opin Pharmacother; 2014 Oct; 15(14):2003-18. PubMed ID: 25139488
[TBL] [Abstract][Full Text] [Related]
8. Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions.
Stevens JW; Khunti K; Harvey R; Johnson M; Preston L; Woods HB; Davies M; Goyder E
Diabetes Res Clin Pract; 2015 Mar; 107(3):320-31. PubMed ID: 25638454
[TBL] [Abstract][Full Text] [Related]
9. Clinical Inquiries: How can we keep impaired glucose tolerance and impaired fasting glucose from progressing to diabetes?
Swanson A; Watrin K; Wilder L
J Fam Pract; 2010 Sep; 59(9):532-3. PubMed ID: 20824232
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of prediabetes in clinical practice: targeting insulin resistance and β-cell dysfunction.
Armato J; DeFronzo RA; Abdul-Ghani M; Ruby R
Endocr Pract; 2012; 18(3):342-50. PubMed ID: 22068250
[TBL] [Abstract][Full Text] [Related]
11. Changes in glucose metabolism in people with different glucose metabolism disorders at baseline: follow-up results of a Finnish national diabetes prevention programme.
Rautio N; Jokelainen J; Oksa H; Saaristo T; Peltonen M; Puolijoki H; Tuomilehto J; Vanhala M; Moilanen L; Uusitupa M; Keinänen-Kiukaanniemi S
Diabet Med; 2015 Dec; 32(12):1611-6. PubMed ID: 25864699
[TBL] [Abstract][Full Text] [Related]
12. Identification and treatment of prediabetes to prevent progression to type 2 diabetes.
Fonseca VA
Clin Cornerstone; 2008; 9(2):51-9; discussion 60-1. PubMed ID: 19410162
[TBL] [Abstract][Full Text] [Related]
13. Drug therapy in prediabetes.
Mukhopadhyay P; Chowdhury S
J Indian Med Assoc; 2005 Nov; 103(11):603-5, 608. PubMed ID: 16570765
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention.
Hostalek U; Gwilt M; Hildemann S
Drugs; 2015 Jul; 75(10):1071-94. PubMed ID: 26059289
[TBL] [Abstract][Full Text] [Related]
15. Prevention of type 2 diabetes in the prediabetic population.
Maji D; Roy RU; Das S
J Indian Med Assoc; 2005 Nov; 103(11):609-11. PubMed ID: 16570766
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic implications of diabetes in cardiovascular disease.
Cherian B; Meka N; Katragadda S; Arora R
Am J Ther; 2009; 16(6):e51-9. PubMed ID: 19940606
[TBL] [Abstract][Full Text] [Related]
17. Delaying the onset of type 2 diabetes mellitus in patients with prediabetes.
Irons BK; Mazzolini TA; Greene RS
Pharmacotherapy; 2004 Mar; 24(3):362-71. PubMed ID: 15040650
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES).
Armato JP; DeFronzo RA; Abdul-Ghani M; Ruby RJ
Lancet Diabetes Endocrinol; 2018 Oct; 6(10):781-789. PubMed ID: 30224284
[TBL] [Abstract][Full Text] [Related]
19. Impaired glucose tolerance: is there a case for pharmacologic intervention?
Costa A; Conget I; Gomis R
Treat Endocrinol; 2002; 1(4):205-10. PubMed ID: 15799213
[TBL] [Abstract][Full Text] [Related]
20. Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes.
Roman G; Hancu N
Horm Metab Res; 2009 Feb; 41(2):116-22. PubMed ID: 19214921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
